Research article · 30 Apr 2017
Conference abstractPublished 2 Sep 2015
Pharmacokinetics of ceftiofur after single intravenous and intramuscular injections in rabbits
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ceftiofur is a broad spectrum third generation cephalosporin antibiotic developed especially for use in animals. The aim of present study is to determine the pharmacokinetics of ceftiofur and its metabolites after single intravenous (IV) and intramuscular (IM) injections at a dose of 2.2 mg/kg BW in rabbits. Six healthy, male, 7-9 months, 3.14±0.28 kg rabbits were used for the study. In pharmacokinetic study, the crossover design was performed. The withdrawal interval between the phases of the study was 15 days. Ceftiofur sodium was administered by IV bolus and IM injections at the dosage of 2.2 mg/kg BW to each rabbit. Plasma concentrations of desfuroylceftiofur were determined using the high-performance liquid chromatography. Plasma concentration–time curve of desfuroylceftiofur was best fitted to a two-compartment open model. Following IV injection, the major pharmacokinetic parameters (mean±SD) were distribution half-life (t1/2α) 0.34±0.07 h, elimination halflife (t1/2β) 2.75±0.59 h, volume of distribution at steady state (Vdss) 260±71 mL/kg, area under the plasma concentrationtime curve (AUC) 20.47±1.86 μg.h/mL, total body clearance (ClT) 108±10 mL.h/kg. After IM administration, the principal pharmacokinetic parameters (mean±SD) were absorption half-life 0.09±0.03 h, peak plasma concentration 9.94±1.35 μg/ mL, time to peak concentration 0.25 h, t1/2α 0.31±0.16 h, t1/2β 2.84±0.68 h, AUC 20.11±2.49 μg.h/mL. The bioavailability after IM injection was 98±4.4%. Results indicated that ceftiofur was absorbed quickly and excellent bioavailability after IM administration. Single IV and IM injections of ceftiofur at a dose of 2.2 mg/kg may be effective to maintain the minimum inhibitory concentration (MIC) upto 12h in rabbits against susceptible pathogens with MIC≤1 μg/ml.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 10 Aug 2015
Comparison the immunogenicity of HIV-1 P24-Nef candidate vaccine conjugated to FliC protein of pseudomonas aeruginosa formulated in Montanide ISA 70 using subcutaneous and intramuscular routes injection in BALB/c mouse model
Research article · 2015
Pharmacokinetics of Orbifloxacin in Mehsana Goats after Intravenous and Intramuscular Administration
Conference abstract · 4 Jan 2017
Comparison of the effects of carbamyl-Ã?²-methylcholine chloride administered by intravenous, intramuscular and intra-acupuncture point injections
Conference abstract · 3 Aug 2015
Comparison of the effects of Carbamyl-β-methylcholine chloride administered by intravenous, intramuscular and intra-acupuncture point injections
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 14 Apr 2026
Ethiopian Child Immunization Coverage Prevalence and Determinants: Evidence from the 2019 Mini-Demographic and Health Survey
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Kamil UNEY”
- BylineArticles whose byline prints “Feray ALTAN”
- BylineArticles whose byline prints “Ayse ER”
- BylineArticles whose byline prints “Enver YAZAR”
- BylineArticles whose byline prints “Muammer ELMAS”
